Leidos (NYSE:LDOS) Announces Quarterly Earnings Results

Leidos (NYSE:LDOS - Get Free Report) released its quarterly earnings results on Tuesday. The aerospace company reported $2.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.47 by $0.50, Zacks reports. Leidos had a return on equity of 30.93% and a net margin of 7.53%. The business had revenue of $4.25 billion during the quarter, compared to the consensus estimate of $4.11 billion. During the same period in the previous year, the company posted $2.29 EPS. The business's quarterly revenue was up 6.8% compared to the same quarter last year. Leidos updated its FY 2025 guidance to 10.350-10.750 EPS.

Leidos Trading Up 0.8 %

NYSE LDOS traded up $1.19 on Friday, hitting $155.90. 1,306,414 shares of the stock were exchanged, compared to its average volume of 1,208,922. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.21. Leidos has a 52-week low of $123.62 and a 52-week high of $202.90. The firm has a market capitalization of $19.99 billion, a P/E ratio of 16.87, a P/E/G ratio of 1.65 and a beta of 0.65. The stock has a fifty day moving average price of $140.16 and a two-hundred day moving average price of $149.31.

Leidos Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a dividend of $0.40 per share. The ex-dividend date is Monday, June 16th. This represents a $1.60 annualized dividend and a yield of 1.03%. Leidos's payout ratio is presently 17.32%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on LDOS. UBS Group increased their price target on shares of Leidos from $149.00 to $168.00 and gave the stock a "neutral" rating in a research report on Wednesday. Royal Bank of Canada boosted their price target on Leidos from $150.00 to $160.00 and gave the company a "sector perform" rating in a report on Wednesday. StockNews.com downgraded Leidos from a "strong-buy" rating to a "buy" rating in a research note on Wednesday, April 30th. Truist Financial dropped their price target on shares of Leidos from $165.00 to $155.00 and set a "buy" rating for the company in a research report on Monday, April 14th. Finally, Wells Fargo & Company boosted their price objective on Leidos from $173.00 to $200.00 and gave the company an "overweight" rating in a research report on Thursday. Five equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $180.69.

Insider Activity

In other Leidos news, Director Gregory R. Dahlberg sold 1,250 shares of the firm's stock in a transaction on Friday, May 9th. The stock was sold at an average price of $154.55, for a total transaction of $193,187.50. Following the transaction, the director now directly owns 20,195 shares in the company, valued at $3,121,137.25. This trade represents a 5.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of Leidos stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $134.56, for a total value of $203,320.16. Following the completion of the sale, the director now owns 6,408 shares of the company's stock, valued at $862,260.48. The trade was a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,889 shares of company stock valued at $675,786. 0.69% of the stock is currently owned by company insiders.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.